Bio-Medical Applications Of Oklahoma Inc is categorized under Kidney Dialysis Centers in Oklahoma City, OK .
Bio-Medical Applications Of Oklahoma Inc was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Kidney Dialysis Centers business, which does work in the B2C market, and is classified as a Kidney Dialysis Centers, under code number 621492 by the NAICS.
If you are seeking more information, feel free to contact Christopher Barnes at the company’s branch by writing to 10301 Greenbriar Parkway, Oklahoma City, Oklahoma OK 73159 or by phoning (405) 691-3433. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Bio-Medical Applications Of Oklahoma Inc |
| Contact Person: | Christopher Barnes |
| Address: | 10301 Greenbriar Parkway, Oklahoma City, Oklahoma 73159 |
| Phone Number: | (405) 691-3433 |
| Annual Revenue (USD): | Unknown |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Kidney Dialysis Centers |
| SIC Code: | 8092 |
| NAICS Code: | 621492 |
| Share This Business: |
Bio-Medical Applications Of Oklahoma Inc was started in 0 to provide professional Kidney Dialysis Centers under the SIC code 8092 and NAICS code 621492. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Christopher Barnes for inquiries that concern Bio-Medical Applications Of Oklahoma Inc by calling the company number (405) 691-3433, as your correspondence is most welcome. Additionally, the physical location of the branch of Bio-Medical Applications Of Oklahoma Inc can be found at the coordinates 35.365022,-97.544708 as well as the street address 10301 Greenbriar Parkway in Oklahoma City, Oklahoma 73159.
For its online presence, you may visit Bio-Medical Applications Of Oklahoma Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.